APA (7th ed.) Citation

Bell, J. B., Sheriff, S., Goryawala, M. Z., Cullison, K., Azzam, G. A., Meshman, J., . . . Mellon, E. A. (2025). Defining occult disease in glioblastoma using spectroscopic MRI: Implications for clinical target volume delineation. Radiation Oncology, 20(1), 1. https://doi.org/10.1186/s13014-025-02666-z

Chicago Style (17th ed.) Citation

Bell, Jonathan B., et al. "Defining Occult Disease in Glioblastoma Using Spectroscopic MRI: Implications for Clinical Target Volume Delineation." Radiation Oncology 20, no. 1 (2025): 1. https://doi.org/10.1186/s13014-025-02666-z.

MLA (9th ed.) Citation

Bell, Jonathan B., et al. "Defining Occult Disease in Glioblastoma Using Spectroscopic MRI: Implications for Clinical Target Volume Delineation." Radiation Oncology, vol. 20, no. 1, 2025, p. 1, https://doi.org/10.1186/s13014-025-02666-z.